238 related articles for article (PubMed ID: 16927043)
1. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
Govoni KE; Baylink DJ; Chen J; Mohan S
Calcif Tissue Int; 2006 Aug; 79(2):112-7. PubMed ID: 16927043
[TBL] [Abstract][Full Text] [Related]
2. The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b.
Brun J; Fromigué O; Dieudonné FX; Marty C; Chen J; Dahan J; Wei Y; Marie PJ
Bone; 2013 Mar; 53(1):6-12. PubMed ID: 23201222
[TBL] [Abstract][Full Text] [Related]
3. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
4. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
[TBL] [Abstract][Full Text] [Related]
5. Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.
König K; Diehl L; Rommerscheidt-Fuss U; Golletz C; Quast T; Kahl P; Kolanus W; Knolle P; Buettner R; Heukamp LC
J Immunol; 2010 Aug; 185(3):1466-75. PubMed ID: 20592280
[TBL] [Abstract][Full Text] [Related]
6. Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts.
Govoni KE; Amaar YG; Kramer A; Winter E; Baylink DJ; Mohan S
Growth Horm IGF Res; 2006 Feb; 16(1):49-56. PubMed ID: 16311053
[TBL] [Abstract][Full Text] [Related]
7. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
[TBL] [Abstract][Full Text] [Related]
8. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo.
Qian Z; Mao L; Fernald AA; Yu H; Luo R; Jiang Y; Anastasi J; Valk PJ; Delwel R; Le Beau MM
Leukemia; 2009 Sep; 23(9):1650-7. PubMed ID: 19369964
[TBL] [Abstract][Full Text] [Related]
10. Four and a half LIM domain protein 2 enhances differentiation and mineralization of human dental pulp cells.
Tian X; Wang Q; Wang X
J Endod; 2015 Apr; 41(4):513-9. PubMed ID: 25662359
[TBL] [Abstract][Full Text] [Related]
11. Transgenic models of metabolic bone disease: impact of estrogen receptor deficiency on skeletal metabolism.
McCauley LK; Tözüm TF; Kozloff KM; Koh-Paige AJ; Chen C; Demashkieh M; Cronovich H; Richard V; Keller ET; Rosol TJ; Goldstein SA
Connect Tissue Res; 2003; 44 Suppl 1():250-63. PubMed ID: 12952206
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2).
Amaar YG; Thompson GR; Linkhart TA; Chen ST; Baylink DJ; Mohan S
J Biol Chem; 2002 Apr; 277(14):12053-60. PubMed ID: 11821401
[TBL] [Abstract][Full Text] [Related]
13. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.
Bai S; Kitaura H; Zhao H; Chen J; Müller JM; Schüle R; Darnay B; Novack DV; Ross FP; Teitelbaum SL
J Clin Invest; 2005 Oct; 115(10):2742-51. PubMed ID: 16184196
[TBL] [Abstract][Full Text] [Related]
14. Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.
Günther T; Poli C; Müller JM; Catala-Lehnen P; Schinke T; Yin N; Vomstein S; Amling M; Schüle R
EMBO J; 2005 Sep; 24(17):3049-56. PubMed ID: 16079911
[TBL] [Abstract][Full Text] [Related]
15. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
Wang Q; Wang X; Tian X; Tang R; Xu X
J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
[TBL] [Abstract][Full Text] [Related]
16. The four-and-a-half LIM domain protein 2 regulates vascular smooth muscle phenotype and vascular tone.
Neuman NA; Ma S; Schnitzler GR; Zhu Y; Lagna G; Hata A
J Biol Chem; 2009 May; 284(19):13202-12. PubMed ID: 19265191
[TBL] [Abstract][Full Text] [Related]
17. Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation.
Kong Y; Shelton JM; Rothermel B; Li X; Richardson JA; Bassel-Duby R; Williams RS
Circulation; 2001 Jun; 103(22):2731-8. PubMed ID: 11390345
[TBL] [Abstract][Full Text] [Related]
18. LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression.
Dahan J; Levillayer F; Xia T; Nouët Y; Werts C; Fanton d'Andon M; Adib-Conquy M; Cassard-Doulcier AM; Khanna V; Chen J; Tordjmann T; Buendia MA; Jouvion G; Wei Y
Mol Cell Biol; 2017 May; 37(10):. PubMed ID: 28223370
[TBL] [Abstract][Full Text] [Related]
19. FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1.
Sun J; Yan G; Ren A; You B; Liao JK
Circ Res; 2006 Sep; 99(5):468-76. PubMed ID: 16888242
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the FHL2 gene attenuates the formation of atherosclerotic lesions after a cholesterol-enriched diet.
Chu PH; Yeh HI; Wu HH; Hong RC; Shiu TF; Yang CM
Life Sci; 2010 Feb; 86(9-10):365-71. PubMed ID: 20096293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
